Oruc, Z. Et Al. 2020. Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study. JOURNAL OF BUON , vol.25, no.2 , 641-647.

Oruc, Z., Kaplan, M. A., Geredeli, C., Sari, N. Y., ÖZASLAN, E., Aytekin, A., ... ELKIRAN, E. T.(2020). Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study. JOURNAL OF BUON , vol.25, no.2, 641-647.

Oruc, Zeynep Et Al. "Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study," JOURNAL OF BUON , vol.25, no.2, 641-647, 2020

Oruc, Zeynep Et Al. "Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study." JOURNAL OF BUON , vol.25, no.2, pp.641-647, 2020

Oruc, Z. Et Al. (2020) . "Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study." JOURNAL OF BUON , vol.25, no.2, pp.641-647.

@article{article, author={Zeynep Oruc Et Al. }, title={Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study}, journal={JOURNAL OF BUON}, year=2020, pages={641-647} }